AMGN241220P205000
- 0.00
- 0.000.00%
Amgen Newsroom
What's Going On With Amgen Stock On Friday?
Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $350
Goldman Sachs, Salesforce Share Gains Lead Dow's 300-Point Jump
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Why Is Novo Nordisk Crashing After Data for Next-gen Weight Loss Drug?
Express News | Shares of Viking Therapeutics up 4.2%, Amgen up 1%
Amgen, Eli Lilly, Viking Therapeutics Shares Rise Pre-Bell After Novo Nordisk's Obesity Treatment Falls Short of Expectations
Amgen Shares Are Trading Higher. Weight-loss Related Stocks Are up on Friday Following Weaker-than-expected Data From Competitor Lilly.
Express News | Amgen Shares up 5.3% Premarket After Novo Nordisk's Obesity Drug Cagrisema Achieves Lower Weight Loss Than Expected
Low-Volatility Funds From Vanguard and Others Sound Ideal for This Market. Why They Might Not Be.
Jefferies Adjusts Amgen Price Target to $350 From $380, Maintains Buy Rating
Hims & Hers Shares Tumble as FDA Resolves Obesity Drug Shortage
Why Is Amgen Inc. (AMGN) Among the Best Dividend Stocks to Invest In?
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Dow's Drop: How Blue-chips Have Fared During Index's Peak Turned Worst-run in Decades
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Merck-Hansoh Deal for Oral GLP-1 Hurts Obesity Drug Developers
FDA Approves Celltrion's Biosimilar of J&J's Stelara
Honeywell's Quantum-computing Business Could Be Worth $20 Billion